))
Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
Manage episode 429238140 series 2910558
Contenuto fornito da CancerCare. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da CancerCare o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV - Current Standard of Care, New & Emerging Treatment Approaches - Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies - Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL - The Role of Clinical Trials: How Research Contributes to Treatment Options - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Talking with Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts
…
continue reading
126 episodi
Condividi
